These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 27003247)

  • 1. Treatment for chronic methicillin-sensitive Staphylococcus aureus pulmonary infection in people with cystic fibrosis.
    Ahmed MI; Mukherjee S
    Cochrane Database Syst Rev; 2016 Mar; 3():CD011581. PubMed ID: 27003247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment for chronic methicillin-sensitive Staphylococcus aureus pulmonary infection in people with cystic fibrosis.
    Ahmed MI; Mukherjee S
    Cochrane Database Syst Rev; 2018 Jul; 7(7):CD011581. PubMed ID: 30052271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interventions for the eradication of methicillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis.
    Lo DK; Hurley MN; Muhlebach MS; Smyth AR
    Cochrane Database Syst Rev; 2013 Feb; (2):CD009650. PubMed ID: 23450608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interventions for the eradication of meticillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis.
    Lo DK; Muhlebach MS; Smyth AR
    Cochrane Database Syst Rev; 2018 Jul; 7(7):CD009650. PubMed ID: 30030966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interventions for the eradication of meticillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis.
    Lo DK; Hurley MN; Muhlebach MS; Smyth AR
    Cochrane Database Syst Rev; 2015 Feb; (2):CD009650. PubMed ID: 25927091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interventions for the eradication of meticillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis.
    Lo DK; Muhlebach MS; Smyth AR
    Cochrane Database Syst Rev; 2022 Dec; 12(12):CD009650. PubMed ID: 36511181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic anti-staphylococcal antibiotics for cystic fibrosis.
    Rosenfeld M; Rayner O; Smyth AR
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD001912. PubMed ID: 32997797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.
    Wood DM; Smyth AR
    Cochrane Database Syst Rev; 2006 Jan; (1):CD004197. PubMed ID: 16437476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic anti-staphylococcal antibiotics for cystic fibrosis.
    Smyth AR; Rosenfeld M
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD001912. PubMed ID: 28417451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic antibiotics for cystic fibrosis.
    Smyth A; Walters S
    Cochrane Database Syst Rev; 2003; (3):CD001912. PubMed ID: 12917916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis.
    Ryan G; Jahnke N; Remmington T
    Cochrane Database Syst Rev; 2012 Dec; 12():CD008319. PubMed ID: 23235659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.
    Waters V; Ratjen F
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD009528. PubMed ID: 28981972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylactic anti-staphylococcal antibiotics for cystic fibrosis.
    Smyth AR; Walters S
    Cochrane Database Syst Rev; 2014 Nov; (11):CD001912. PubMed ID: 25419599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic anti-staphylococcal antibiotics for cystic fibrosis.
    Smyth AR; Walters S
    Cochrane Database Syst Rev; 2012 Dec; 12():CD001912. PubMed ID: 23235585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral anti-pseudomonal antibiotics for cystic fibrosis.
    Remmington T; Jahnke N; Harkensee C
    Cochrane Database Syst Rev; 2016 Jul; 7(7):CD005405. PubMed ID: 27412131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.
    Waters V; Ratjen F
    Cochrane Database Syst Rev; 2015 Mar; (3):CD009528. PubMed ID: 25741986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral anti-pseudomonal antibiotics for cystic fibrosis.
    Remmington T; Jahnke N; Harkensee C
    Cochrane Database Syst Rev; 2007 Jul; (3):CD005405. PubMed ID: 17636796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral anti-pseudomonal antibiotics for cystic fibrosis.
    Remmington T; Jahnke N; Harkensee C
    Cochrane Database Syst Rev; 2013 Oct; (10):CD005405. PubMed ID: 24170644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.
    Langton Hewer SC; Smyth AR
    Cochrane Database Syst Rev; 2009 Oct; (4):CD004197. PubMed ID: 19821321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.
    Smith S; Waters V; Jahnke N; Ratjen F
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD009528. PubMed ID: 32520436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.